Hoertkorn Richard Charles’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $840K | Hold |
700
| – | – | 0.56% | 26 |
|
|
2026
Q1 | $644K | Hold |
700
| – | – | 0.53% | 31 |
|
|
2025
Q4 | $752K | Hold |
700
| – | – | 0.29% | 34 |
|
|
2025
Q3 | $534K | Hold |
700
| – | – | 0.21% | 34 |
|
|
2025
Q2 | $546K | Hold |
700
| – | – | 0.23% | 35 |
|
|
2025
Q1 | $578K | Hold |
700
| – | – | 0.27% | 35 |
|
|
2024
Q4 | $540K | Hold |
700
| – | – | 0.22% | 35 |
|
|
2024
Q3 | $620K | Hold |
700
| – | – | 0.27% | 35 |
|
|
2024
Q2 | $634K | Hold |
700
| – | – | 0.28% | 37 |
|
|
2024
Q1 | $545K | Hold |
700
| – | – | 0.23% | 36 |
|
|
2023
Q4 | $408K | Hold |
700
| – | – | 0.18% | 39 |
|
|
2023
Q3 | $376K | Hold |
700
| – | – | 0.19% | 38 |
|
|
2023
Q2 | $328K | Hold |
700
| – | – | 0.16% | 41 |
|
|
2023
Q1 | $240K | Hold |
700
| – | – | 0.12% | 42 |
|
|
2022
Q4 | $256K | Hold |
700
| – | – | 0.14% | 40 |
|
|
2022
Q3 | $226K | Hold |
700
| – | – | 0.13% | 39 |
|
|
2022
Q2 | $227K | Hold |
700
| – | – | 0.12% | 40 |
|
|
2022
Q1 | $200K | Hold |
700
| – | – | 0.09% | 42 |
|
|
2021
Q4 | $193K | Hold |
700
| – | – | 0.08% | 43 |
|
|
2021
Q3 | $162K | Hold |
700
| – | – | 0.07% | 43 |
|
|
2021
Q2 | $161K | Hold |
700
| – | – | 0.07% | 45 |
|
|
2021
Q1 | $131K | Hold |
700
| – | – | 0.06% | 47 |
|
|
2020
Q4 | $118K | Hold |
700
| – | – | 0.06% | 49 |
|
|
2020
Q3 | $104K | Sell |
700
-100
| -13% | -$15.5K | 0.07% | 52 |
|
|
2020
Q2 | $131K | Hold |
800
| – | – | 0.09% | 46 |
|
|
2020
Q1 | $111K | Hold |
800
| – | – | 0.09% | 49 |
|
|
2019
Q4 | $105K | Hold |
800
| – | – | 0.06% | 53 |
|
|
2019
Q3 | $89K | Hold |
800
| – | – | 0.06% | 55 |
|
|
2019
Q2 | $89K | Hold |
800
| – | – | 0.06% | 54 |
|
|
2019
Q1 | $104K | Hold |
800
| – | – | 0.07% | 51 |
|
|
2018
Q4 | $93K | Sell |
800
-100
| -11% | -$11.2K | 0.07% | 56 |
|
|
2018
Q3 | $97K | Sell |
900
-100
| -10% | -$10K | 0.06% | 59 |
|
|
2018
Q2 | $85K | Hold |
1,000
| – | – | 0.05% | 60 |
|
|
2018
Q1 | $77K | Sell |
1,000
-225
| -18% | -$18.1K | 0.05% | 62 |
|
|
2017
Q4 | $103K | Hold |
1,225
| – | – | 0.06% | 57 |
|
|
2017
Q3 | $105K | Hold |
1,225
| – | – | 0.07% | 53 |
|
|
2017
Q2 | $101K | Hold |
1,225
| – | – | 0.07% | 54 |
|
|
2017
Q1 | $103K | Hold |
1,225
| – | – | 0.07% | 55 |
|
|
2016
Q4 | $90K | Sell |
1,225
-75
| -6% | -$5.58K | 0.06% | 58 |
|
|
2016
Q3 | $104K | Hold |
1,300
| – | – | 0.08% | 55 |
|
|
2016
Q2 | $102K | Hold |
1,300
| – | – | 0.08% | 56 |
|
|
2016
Q1 | $94K | Hold |
1,300
| – | – | 0.08% | 58 |
|
|
2015
Q4 | $110K | Hold |
1,300
| – | – | 0.08% | 58 |
|
|
2015
Q3 | $109K | Sell |
1,300
-200
| -13% | -$16.9K | 0.09% | 57 |
|
|
2015
Q2 | $125K | Hold |
1,500
| – | – | 0.09% | 51 |
|
|
2015
Q1 | $109K | Hold |
1,500
| – | – | 0.08% | 55 |
|
|
2014
Q4 | $104K | Hold |
1,500
| – | – | 0.07% | 55 |
|
|
2014
Q3 | $97K | Hold |
1,500
| – | – | 0.07% | 53 |
|
|
2014
Q2 | $93K | Hold |
1,500
| – | – | 0.07% | 56 |
|
|
2014
Q1 | $88K | Sell |
1,500
-559
| -27% | -$31.2K | 0.07% | 54 |
|
|
2013
Q4 | $105K | Buy |
+2,059
| New | +$103K | 0.08% | 50 |
|
Other funds holding LLY
SC
ONB
GIM
Hoertkorn Richard Charles's LLY Position: Q2 2026 in Review
Hoertkorn Richard Charles held its Eli Lilly (LLY) position steady in Q2 2026 at 700 shares worth $840K. The position accounts for 0.56% of the portfolio, ranked #26.
Hoertkorn Richard Charles first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hoertkorn Richard Charles held 700 shares of Eli Lilly worth $840K as of Q2 2026.
- Hoertkorn Richard Charles left its Eli Lilly share count unchanged in Q2 2026.
- Eli Lilly made up 0.56% of Hoertkorn Richard Charles's portfolio in Q2 2026, its #26 holding.
- Hoertkorn Richard Charles first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
- 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hoertkorn Richard Charles's 13F filing for Q2 2026, filed 23 Jul 2026.